Lumos Pharma's market cap is currently ―. The company's EPS TTM is $-4.192; its P/E ratio is -0.65; Lumos Pharma is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-1.14. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 7.00K	$ 527.00K	$ 691.00K	$ 512.00K	$ 497.00K
Gross Profit	$ 7.00K	$ 527.00K	$ 691.00K	$ 512.00K	-
EBIT	$ -8.30M	$ -8.96M	$ -7.35M	$ -8.76M	$ -7.25M
EBITDA	$ -8.29M	$ -8.95M	$ -7.34M	$ -8.73M	$ -7.25M
Net Income Common Stockholders	$ -8.30M	$ -8.93M	$ -7.35M	$ -8.25M	$ -7.25M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 42.69M	$ 50.85M	$ 57.98M	$ 67.36M	$ 73.67M
Total Assets	$ 47.75M	$ 56.37M	$ 63.73M	$ 72.29M	$ 79.21M
Total Debt	$ 269.00K	$ 346.00K	$ 421.00K	$ 233.00K	$ 313.00K
Net Debt	$ -42.42M	$ -50.51M	$ -57.56M	$ -67.13M	$ -73.35M
Total Liabilities	$ 12.26M	$ 12.71M	$ 11.21M	$ 12.71M	$ 11.50M
Stockholders Equity	$ 35.49M	$ 43.66M	$ 52.52M	$ 59.58M	$ 67.71M
Cash Flow	-
Free Cash Flow	$ -7.82M	$ -6.68M	$ -9.20M	$ -5.85M	$ -5.52M
Operating Cash Flow	$ -7.82M	$ -6.68M	$ -9.20M	$ -5.83M	$ -5.52M
Investing Cash Flow	$ 5.95M	$ 1.08M	$ -2.46M	$ -11.36M	$ 0.00
Financing Cash Flow	$ -435.00K	$ -574.00K	$ -309.00K	$ -475.00K	$ -326.00K

Currency in USD

Lumos Pharma Earnings and Revenue History

Income Statement >

Lumos Pharma Debt to Assets

Balance Sheet >

Lumos Pharma Cash Flow

Cash Flow >

Lumos Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing